Cargando…

Validation of the Dutch Version of the Boston Carpal Tunnel Questionnaire

The Boston Carpal Tunnel Questionnaire (BCTQ) is a scale that has been developed specifically for carpal tunnel syndrome (CTS). It consists of the Functional Status Scale (FSS) and the Symptom Severity Scale (SSS). It is the most widely used patient reported outcome measure in CTS and has been valid...

Descripción completa

Detalles Bibliográficos
Autores principales: De Kleermaeker, Floriaan G. C. M., Levels, Mark, Verhagen, Wim I. M., Meulstee, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854027/
https://www.ncbi.nlm.nih.gov/pubmed/31787920
http://dx.doi.org/10.3389/fneur.2019.01154
_version_ 1783470155484889088
author De Kleermaeker, Floriaan G. C. M.
Levels, Mark
Verhagen, Wim I. M.
Meulstee, Jan
author_facet De Kleermaeker, Floriaan G. C. M.
Levels, Mark
Verhagen, Wim I. M.
Meulstee, Jan
author_sort De Kleermaeker, Floriaan G. C. M.
collection PubMed
description The Boston Carpal Tunnel Questionnaire (BCTQ) is a scale that has been developed specifically for carpal tunnel syndrome (CTS). It consists of the Functional Status Scale (FSS) and the Symptom Severity Scale (SSS). It is the most widely used patient reported outcome measure in CTS and has been validated in many languages. Although already widely used, psychometric properties of the Dutch version of the BCTQ are yet unknown. The aim of this study was to assess the validity, reliability, responsiveness, and acceptability of the Dutch version. Moreover, this paper focuses the longitudinal validity (the use after an intervention) of the BCTQ, which has not been investigated before. A total of 180 patients completed the BCTQ in addition to a six-point Likert scale for perceived improvement, before and about 6–8 months after carpal tunnel release (CTR). Principal factor analysis revealed that the FSS is unidimensional, consisting of a single latent factor (“functionality”) and has a high internal consistency (Cronbach's α = 0.825). However, the SSS has three dimensions, which are all highly internally consistent: “daytime symptoms” (Cronbach's α = 0.805), “nighttime symptoms” (Cronbach's α = 0.835), and “operational capacity” (Cronbach's α = 0.723). Post-treatment, the FSS still consisted of one factor, but the SSS changed in dimensionality, as it had only two factors left post-treatment. The ΔFSS and ΔSSS had good correlation with the six-point Likert scale for perceived improvement (r = 0.524; p < 0.01 and r = 0.574; p < 0.01, respectively), a moderate correlation between FSS and pinch grip (r = 0.259; p < 0.01) was found, and a weak correlation between SSS and pinch grip (r = 0.231; p < 0.01) was found. Standard Response Mean for FSS and SSS was 0.76 and 1.49, respectively. Effect size was 0.92 and 1.96, respectively, both indicating a good responsiveness. Response rate was high (82–84%). We concluded that the Dutch version of the BCTQ has a proper reliability, validity, responsiveness, and acceptability to assess the symptom severity and functional disabilities of CTS patients. Because of multidimensionality, we would recommend to create sum scores of the four different dimensions instead of two. Caution is required when interpreting the results postoperatively, due to the insufficient longitudinal validity of the SSS.
format Online
Article
Text
id pubmed-6854027
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-68540272019-11-29 Validation of the Dutch Version of the Boston Carpal Tunnel Questionnaire De Kleermaeker, Floriaan G. C. M. Levels, Mark Verhagen, Wim I. M. Meulstee, Jan Front Neurol Neurology The Boston Carpal Tunnel Questionnaire (BCTQ) is a scale that has been developed specifically for carpal tunnel syndrome (CTS). It consists of the Functional Status Scale (FSS) and the Symptom Severity Scale (SSS). It is the most widely used patient reported outcome measure in CTS and has been validated in many languages. Although already widely used, psychometric properties of the Dutch version of the BCTQ are yet unknown. The aim of this study was to assess the validity, reliability, responsiveness, and acceptability of the Dutch version. Moreover, this paper focuses the longitudinal validity (the use after an intervention) of the BCTQ, which has not been investigated before. A total of 180 patients completed the BCTQ in addition to a six-point Likert scale for perceived improvement, before and about 6–8 months after carpal tunnel release (CTR). Principal factor analysis revealed that the FSS is unidimensional, consisting of a single latent factor (“functionality”) and has a high internal consistency (Cronbach's α = 0.825). However, the SSS has three dimensions, which are all highly internally consistent: “daytime symptoms” (Cronbach's α = 0.805), “nighttime symptoms” (Cronbach's α = 0.835), and “operational capacity” (Cronbach's α = 0.723). Post-treatment, the FSS still consisted of one factor, but the SSS changed in dimensionality, as it had only two factors left post-treatment. The ΔFSS and ΔSSS had good correlation with the six-point Likert scale for perceived improvement (r = 0.524; p < 0.01 and r = 0.574; p < 0.01, respectively), a moderate correlation between FSS and pinch grip (r = 0.259; p < 0.01) was found, and a weak correlation between SSS and pinch grip (r = 0.231; p < 0.01) was found. Standard Response Mean for FSS and SSS was 0.76 and 1.49, respectively. Effect size was 0.92 and 1.96, respectively, both indicating a good responsiveness. Response rate was high (82–84%). We concluded that the Dutch version of the BCTQ has a proper reliability, validity, responsiveness, and acceptability to assess the symptom severity and functional disabilities of CTS patients. Because of multidimensionality, we would recommend to create sum scores of the four different dimensions instead of two. Caution is required when interpreting the results postoperatively, due to the insufficient longitudinal validity of the SSS. Frontiers Media S.A. 2019-11-07 /pmc/articles/PMC6854027/ /pubmed/31787920 http://dx.doi.org/10.3389/fneur.2019.01154 Text en Copyright © 2019 De Kleermaeker, Levels, Verhagen and Meulstee. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
De Kleermaeker, Floriaan G. C. M.
Levels, Mark
Verhagen, Wim I. M.
Meulstee, Jan
Validation of the Dutch Version of the Boston Carpal Tunnel Questionnaire
title Validation of the Dutch Version of the Boston Carpal Tunnel Questionnaire
title_full Validation of the Dutch Version of the Boston Carpal Tunnel Questionnaire
title_fullStr Validation of the Dutch Version of the Boston Carpal Tunnel Questionnaire
title_full_unstemmed Validation of the Dutch Version of the Boston Carpal Tunnel Questionnaire
title_short Validation of the Dutch Version of the Boston Carpal Tunnel Questionnaire
title_sort validation of the dutch version of the boston carpal tunnel questionnaire
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854027/
https://www.ncbi.nlm.nih.gov/pubmed/31787920
http://dx.doi.org/10.3389/fneur.2019.01154
work_keys_str_mv AT dekleermaekerfloriaangcm validationofthedutchversionofthebostoncarpaltunnelquestionnaire
AT levelsmark validationofthedutchversionofthebostoncarpaltunnelquestionnaire
AT verhagenwimim validationofthedutchversionofthebostoncarpaltunnelquestionnaire
AT meulsteejan validationofthedutchversionofthebostoncarpaltunnelquestionnaire